Nachrichten zur Astellas Pharma, Inc. Aktie

$49 Billion Worldwide Genito-Urinary Drugs Industry to 2030 - Featuring Pfizer, Astellas Pharma and Allergan Among Others

DUBLIN, May 11, 2021 /PRNewswire/ -- The "Genito-Urinary Drugs Global Market Report 2021: COVID-19 Impact and Recovery to 2030" report…

EPIX: Combination Trials Upcoming with Astellas, Bayer, and Janssen…

By David Bautz, PhD NASDAQ:EPIX READ THE FULL EPIX RESEARCH REPORT read more...…

Astellas: European Commission Approves Additional Indication For XTANDI

BRUSSELS/FRANKFURT/PARIS (dpa-AFX) - Astellas Pharma Inc. (ALPMY, ALPMY) said the European Commission has approved an additional indication for the oral…

Astellas Walks Away From $450M Research & Discovery Partnership With Cytokinetics

Astellas Pharma, Inc. (ALPMF) CEO Kenji Yasukawa on Q4 2021 Results - Earnings Call Transcript

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Astellas Takes $540M Impairment Charge Of $3B Audentes Buyout On Gene Therapy Trial Hold

Astellas Pharma Inc. 2020 Q4 - Results - Earnings Call Presentation

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Worldwide Anaplastic Lymphoma Kinase ALK Inhibitors Industry to 2026 - Featuring Astellas Pharma, AstraZeneca ad Pfizer Among Others

DUBLIN, April 22, 2021 /PRNewswire/ -- The "Global Anaplastic Lymphoma Kinase ALK Inhibitors Market, Drug Sales, Price & Clinical Trials…

Seagen: FDA Accepts Two SBLA For PADCEV In Locally Advanced Or Metastatic Urothelial Cancer

TOKYO (dpa-AFX) - Seagen Inc. (SGEN) and Astellas Pharma Inc. said that the U.S. Food and Drug Administration has accepted…

Global Acute Myeloid Leukemia (AML) Disease Market Report 2021 Featuring Apollomics, Astellas, BerGenBio, Chimerix, Daiichi Sankyo, Forma, GlycoMimetics, Kiadis, MacroGenics, Medigene & Piramal

DUBLIN, April 14, 2021 /PRNewswire/ -- The "Disease Analysis: Acute Myeloid Leukemia (AML)" report has been added to ResearchAndMarkets.coms offering.…

XFRA : INSTRUMENT_EVENT EQUBF_01

DIVIDEND/INTEREST INFORMATION - 30.03.2021:Das Instrument YPH JP3942400007 ASTELLAS PHARMA INC. EQUITY wird cum Dividende/Zinsen gehandelt am 29.03.2021 und ex…

Astellas wins FDA approval for new Myrbetriq indication and formulation

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Astellas: FDA Approves Myrbetriq For Children With Neurogenic Detrusor Overactivity

TOKYO (dpa-AFX) - Astellas Pharma Inc. (ALPMY, ALPMY) said Friday that the U.S. Food and Drug Administration approved Myrbetriq (mirabegron…

Astellas Gets Positive CHMP Opinion For XTANDI On Metastatic Hormone-Sensitive Prostate Cancer

TOKYO (dpa-AFX) - Astellas Pharma Inc. (ALPMY, ALPMY) said that the Committee for Medicinal Products for Human Use or CHMP…

Seagen: EMA Accepts MAA Of Enfortumab Vedotin For Urothelial Cancer Treatment

WASHINGTON (dpa-AFX) - Astellas Pharma Inc. and Seagen Inc. (SGEN) said that the European Medicines Agency or EMA accepted a…

Astellas Submits New Drug Application for Enfortumab Vedotin in Japan

TOKYO , March 11, 2021 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO:…

ESSA Pharma Announces Clinical Collaboration with Astellas to Evaluate the Combination of EPI-7386 and Enzalutamide for Patients with Metastatic Castration-Resistant Prostate Cancer

HOUSTON, Texas and VANCOUVER, Canada , Feb. 25, 2021 /PRNewswire/…

Seagen (SGEN), Astellas Submit 2 sBLAs to FDA for Urothelial Cancer

Seagen (SGEN) and Astellas Pharma announced completion of submissions of two sBLAs to the FDA for Padcev in patients with…

Astellas Announces Positive Topline Results from Two Phase 3 Pivotal Global Trials of Fezolinetant for the Nonhormonal Treatment of Vasomotor Symptoms in Postmenopausal Women

TOKYO , Feb. 19, 2021 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503) (President and CEO:…

Astellas and Seagen submit two approval requests for bladder cancer therapy

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Astellas and Seagen Announce Phase 3 Trial Results Demonstrating Survival Advantage of PADCEV® (enfortumab vedotin-ejfv) in Patients with Previously Treated Advanced Urothelial Cancer

TOKYO and BOTHELL, Wash. , Feb. 12, 2021 /PRNewswire/ --…

Astellas Pharma Inc. 2021 Q3 - Results - Earnings Call Presentation

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Astellas Pharma reports 9M results

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

FibroGen announces supply deal for roxadustat with Astellas

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Actinium, Astellas in research pact for radiotherapies

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Actinium and Astellas Announce Research Collaboration Focused on Novel Actinium-225 Based Targeted Radiotherapies

NEW YORK , Jan. 13, 2021 /PRNewswire/ -- Actinium Pharmaceuticals, Inc. …

Astellas xospata misses primary endpoint in late-stage leukemia study

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

KaliVir Immunotherapeutics inks agreement with Astellas for development and commercialization of VET2-L2 novel oncolytic virus

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

KaliVir Immunotherapeutics and Astellas Enter Worldwide Exclusive Licensing Agreement for Development and Commercialization of VET2-L2 Novel Oncolytic Virus

PITTSBURGH and TOKYO , Dec. 7, 2020 /PRNewswire/ -- KaliVir Immunotherapeutics…

Astellas Receives Approval of EVRENZO® (roxadustat) in Japan for the Treatment of Anemia of Chronic Kidney Disease in Adult Patients Not on Dialysis

Approval by MHLW provides new HIF-PH inhibitor treatment option for healthcare providers and adult patients with anemia of CKD not…

Astellas gets Japanese approval for Evrenzo to treat anaemia of CKD in adult patients not on dialysis

In 2019, Astellas and FibroGen have also received Japanese approval for roxadustat for the treatment of adult patients with anaemia…

Astellas Receives Approval of EVRENZO® (roxadustat) in Japan for the Treatment of Anemia of Chronic Kidney Disease in Adult Patients Not on Dialysis

TOKYO , Nov. 27, 2020 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO:…

Astellas to Present New Data on Gilteritinib in FLT3 Mutation-Positive Acute Myeloid Leukemia at the 2020 American Society of Hematology Annual Meeting

TOKYO , Nov. 16, 2020 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO:…

XTANDI® (enzalutamide soft capsules) Approved by China NMPA for the Treatment of Non-Metastatic Castration-Resistant Prostate Cancer

TOKYO , Nov. 6, 2020 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO:…

Astellas Pharma Inc. (ALPMY) Kenji Yasukawa on Q2 2020 Results - Earnings Call Transcript

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Astellas Pharma Inc. 2020 Q2 - Results - Earnings Call Presentation

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Astellas Receives U.S. FDA Fast Track Designation for ASP5354, an Investigational Near-Infrared Fluorescence Imaging Agent

TOKYO , Oct. 28, 2020 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO:…

Astellas and Seagen Announce Positive Topline Results from Second Cohort of Patients in Phase 2 Pivotal Trial of PADCEV® (enfortumab vedotin-ejfv) in Advanced Urothelial Cancer

TOKYO and BOTHELL, Wash. , Oct. 12, 2020 /PRNewswire/ -- Astellas…

Astellas and LabCentral Announce Golden Ticket Winners - Helping Emerging Biotechs Accelerate Growth of Innovative Science

CAMBRIDGE, Mass. , Oct. 8, 2020 /PRNewswire/ -- Astellas Venture Management LLC (President: …

Astellas and MBC BioLabs Announce Golden Ticket Competition to Help Biotech Start-ups Accelerate Early Drug Discovery and Research Efforts

TOKYO and SAN FRANCISCO , Sept. 29, 2020 /PRNewswire/ -- Astellas Venture Management (President:…

Eine Umfrage zeigt die physische und psychische Belastung bei Anämie aufgrund einer chronischen Nierenerkrankung, wobei 41 % der Patienten angeben, sich sozial isoliert zu fühlen

Astellas Pharma Europe Limited: Addlestone, England (ots/PRNewswire) - - Mehr als die Hälfte der befragten Patienten gab an, dass ihre…

Astellas and Seattle Genetics Announce PADCEV® (enfortumab vedotin-ejfv) Significantly Improved Overall Survival in Phase 3 Trial in Previously Treated Locally Advanced or Metastatic Urothelial Cancer

TOKYO and BOTHELL, Wash. , Sept. 18, 2020 /PRNewswire/ -- …

Final PROSPER Results Show XTANDI® (enzalutamide) Significantly Extends Overall Survival in Men with Non-Metastatic Castration-Resistant Prostate Cancer

NEW YORK and TOKYO , May 29, 2020 /PRNewswire/ -- Pfizer…